Azabicyclic heterocycles as cannabinoid receptor modulators

Details Azabicyclic heterocycles as cannabinoid receptor modulators Azabicyclic heterocycles as cannabinoid receptor modulators

2006-05-02

2006-05-02

Balasubramanian, Venkataraman (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C544S184000

Reexamination Certificate

active

07037910

ABSTRACT:
The present application describes compounds according to Formula I, pharmaceutical compositions comprising at least one compound according to Formula I and optionally one or more additional therapeutic agents and methods of treatment using the compounds according to Formula I both alone and in combination with one or more additional therapeutic agents. The compounds have the general Formula Iincluding all prodrugs, pharmaceutically acceptable salts and stereoisomers, R1, R2, R3, and R4are described herein.

REFERENCES:
patent: 4581449 (1986-04-01), Parravicini et al.
patent: 6610694 (2003-08-01), Kawano et al.
patent: 2004/0063580 (2004-04-01), Kuragano et al.
patent: WO 00/20417 (2000-04-01), None
patent: WO 02/38562 (2002-05-01), None
patent: WO 2004/074259 (2004-09-01), None
Wolft Manfred E. “Burger's Medicinal Chemistry, 5ed, Part 1”, John Wiley & Sons, 1995, pp. 975-977.
Banker, G.S. et al, “Modern Pharmaceutices, 3ed.”, Marcel Dekker, New York. 1996, pp. 451 and 596.
Petrocellis et al., British Journal of Pharmacology, 141, 765-774.
Black, Curr. Opin.. Investig. Drugs 5(4): 389-394, 2004.
Cecil Textbook of Medicine, edited by Bennet, J.C., and Plum F., 20th edition,vol. 1, 1004-1010, 1996.
U.S. Appl. No. 11/016,135, filed Dec. 17, 2004, Yu et al.
U.S. Appl. No. 11/016,198, filed Dec. 17, 2004, Yu et al.
Deeb, A. et al., “Studies on Polyazaindenes Synthesis of Several New Condensed Pyridazine Derivatives”, Collect. Czech. Chem. Commun., vol. 55, pp. 2795-2799 (1990).

Affiliated with

Also associated with

Rating

Azabicyclic heterocycles as cannabinoid receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azabicyclic heterocycles as cannabinoid receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azabicyclic heterocycles as cannabinoid receptor modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3543472